140 related articles for article (PubMed ID: 19680626)
1. Diabetic retinopathy and insulin glargine.
Chantelau E
Diabetologia; 2009 Oct; 52(10):2233; author reply 2236-9. PubMed ID: 19680626
[No Abstract] [Full Text] [Related]
2. The longest ever randomised controlled trial of insulin glargine: study design and HbA(1c) findings.
Currie CJ
Diabetologia; 2009 Oct; 52(10):2234-5; author reply 2236-9. PubMed ID: 19662377
[No Abstract] [Full Text] [Related]
3. Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study.
Rosenstock J; Fonseca V; McGill JB; Riddle M; Hallé JP; Hramiak I; Johnston P; Davis M
Diabetologia; 2009 Sep; 52(9):1971-3. PubMed ID: 19609501
[No Abstract] [Full Text] [Related]
4. Insulin glargine clinical trials.
White JR
Clin Ther; 2004 Jul; 26(7):1179-81; discussion 1182-3. PubMed ID: 15336483
[No Abstract] [Full Text] [Related]
5. Long-acting insulin analogues and diabetic retinopathy: a retrospective cohort study.
Lin JC; Shau WY; Lai MS
Clin Ther; 2014 Sep; 36(9):1255-68. PubMed ID: 25082730
[TBL] [Abstract][Full Text] [Related]
6. Insulin detemir (levemir), a new long-acting insulin.
Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
[TBL] [Abstract][Full Text] [Related]
7. Insulin glargine (Lantus) and cancer risk.
Med Lett Drugs Ther; 2009 Aug; 51(1319):67-8. PubMed ID: 19696708
[No Abstract] [Full Text] [Related]
8. Insulin glargine: a new basal insulin analogue.
Younis N; Soran H; Bowen-Jones D
QJM; 2002 Nov; 95(11):757-61. PubMed ID: 12391389
[No Abstract] [Full Text] [Related]
9. Initiating basal insulin therapy in patients with type 2 diabetes mellitus.
Stoneking K
Am J Health Syst Pharm; 2005 Mar; 62(5):510-8. PubMed ID: 15745915
[No Abstract] [Full Text] [Related]
10. [Increased risk of cancer using insulin and insulin analogues?].
Schäffler A
MMW Fortschr Med; 2010 Sep; 152(36):39-41. PubMed ID: 21192466
[No Abstract] [Full Text] [Related]
11. Editorial: glargine, a new long-acting insulin analog for diabetic cats.
Rand J
J Vet Intern Med; 2006; 20(2):219-20. PubMed ID: 16594574
[No Abstract] [Full Text] [Related]
12. Insulin glargine and its role in glycaemic management of Type 2 diabetes.
Elrishi MA; Jarvis J; Khunti K; Davies MJ
Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1099-110. PubMed ID: 18680444
[TBL] [Abstract][Full Text] [Related]
13. Insulin glargine: a systematic review of a long-acting insulin analogue.
Wang F; Carabino JM; Vergara CM
Clin Ther; 2003 Jun; 25(6):1541-77, discussion 1539-40. PubMed ID: 12860485
[TBL] [Abstract][Full Text] [Related]
14. Insulin glargine in continuous enteric tube feeding.
Putz D; Kabadi UM
Diabetes Care; 2002 Oct; 25(10):1889-90. PubMed ID: 12351503
[No Abstract] [Full Text] [Related]
15. Basal insulin glargine vs prandial insulin lispro in type 2 diabetes.
Oliveira JH; Kazda C; Simpson A; Jackson JA; Heine RJ
Lancet; 2008 Aug; 372(9636):371-2; author reply 372. PubMed ID: 18675683
[No Abstract] [Full Text] [Related]
16. Increased insulin dose requirement of long-acting insulin analogues in obese patients with type 2 diabetes.
Schmid C; Krayenbühl P; Wiesli P
Diabetologia; 2009 Dec; 52(12):2668-9. PubMed ID: 19774359
[No Abstract] [Full Text] [Related]
17. Insulin glargine controversy: a tribute to the editorial team at Diabetologia.
Butler PC
Diabetes; 2009 Nov; 58(11):2427-8. PubMed ID: 19875618
[No Abstract] [Full Text] [Related]
18. Insulin glargine: commentary on the duration of action and lower risk of nocturnal hypoglycaemia in patients with diabetes.
Rosenstock J; Owens D
Expert Opin Pharmacother; 2004 Jan; 5(1):1-2; author reply 2-3. PubMed ID: 14680430
[No Abstract] [Full Text] [Related]
19. Combined randomised controlled trial experience of malignancies in studies using insulin glargine.
Home PD; Lagarenne P
Diabetologia; 2009 Dec; 52(12):2499-506. PubMed ID: 19756478
[TBL] [Abstract][Full Text] [Related]
20. [When oral therapy of type 2 diabetes fails--basal insulin is more effective than change in life style (interview by Dr. Thomas Meissner)].
MMW Fortschr Med; 2008 Aug; 150(32-35):28-9. PubMed ID: 19006878
[No Abstract] [Full Text] [Related]
[Next] [New Search]
